Company: CLX
Filing Date: 2025-02-03
Form Type: 10-Q
Source: 0000021076-25-000013
Chunk: 63

Company: CLOROX CO /DE/
Filing Date: 2025-02-03
Form: 10-Q
Item: Part I, Item 8
Chunk 63
---
 $2,345 (1)Cash and cash equivalents are composed of time deposits and other interest-bearing investments, including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.(2)Notes and loans payable are composed of outstanding U.S. commercial paper balances and/or amounts drawn on the Company’s credit agreements, all of which are recorded at cost, which approximates fair value. The weighted average effective interest rate on Notes and loan payable balances as of December 31, 2024 and June 30, 2024 were 4.67% and 5.60%, respectively. (3)Long-term debt is recorded at cost. The fair value of Long-term debt was determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.

12

NOTE 8. OTHER (INCOME) EXPENSE, NET

The major components of Other (income) expense, net were:Three months endedSix months ended12/31/202412/31/202312/31/202412/31/2023Amortization of trademarks and other intangible assets$5 $7 $11 $15 Trust investment (gains) losses, net1 (12)(8)(10)Net periodic benefit (credit) cost (4)5 (3)10 Foreign exchange transaction (gains) losses, net (1)2 15 3 23 Income from equity investees(1)(1)(3)(2)Interest income(2)(7)(5)(17)Gain on sale-leaseback transaction (2)— (16)— (16)Cyberattack insurance recoveries (3)(23)— (32)— Other(1)2 (8)2 Total$(23)$(7)$(45)$5 (1)Foreign exchange losses were primarily related to the Company’s operations in Argentina in the three and six month periods ended December 31, 2023.(2)On December 14, 2023, the Company completed an asset sale-leaseback transaction on a warehouse in Fairfield, California. The transaction resulted in a $16 gain which was recognized in Other (income) expense, net in the Health and Wellness segment. Refer to Notes to Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024 for further information